Skip to content

A prospective, randomized controlled trial to evaluate platelet-rich plasma for promoting postoperative recovery in patients undergoing lobectomy

A prospective, randomized controlled trial to evaluate platelet-rich plasma for promoting postoperative recovery in patients undergoing lobectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107329
Enrollment
Unknown
Registered
2025-08-08
Start date
2024-07-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Test Group:Platelet-rich plasma is sprayed at the bronchial stump
Control group:None

Sponsors

The Affiliated Hospital of Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Male or female patients aged between 18 and 80. 2. Patients diagnosed as requiring lobectomy, including but not limited to those with lung cancer, benign lung tumors or other lung diseases that require surgical treatment. 3. Pulmonary function assessment: the results of the pulmonary function test show that the patient is tolerant to the surgery 4.The results of the blood routine test show that all the patient's blood indicators are within the normal range 5. Normal liver function 6.The results of the electrocardiogram (ECG) and echocardiogram tests show that the heart function is positive,there are often or only mild abnormalities, and no history of serious heart disease. 7. The patient is capable and willing to have 150ml of venous blood drawn one day before the operation for the preparation of platelet-rich plasma (PRP). 8. The patient voluntarily participated in this study and has thoroughly understood the study content, process, possible risks and benefits. 9. No serious mental or psychological disorders, and able to cooperate to complete the entire research process.

Exclusion criteria

Exclusion criteria: 1. Patients with severe coagulation dysfunction; 2. Patients allergic to blood products; 3. Patients who have used other drugs or treatments that may affect postoperative healing before the operation; 4. Situations where other researchers consider it inappropriate to participate in this study.

Design outcomes

Primary

MeasureTime frame
Postoperative thoracic drainage volume; The incidence of postoperative air leakage;

Secondary

MeasureTime frame
Postoperative hospital stay;

Countries

China

Contacts

Public ContactYongjie Wang

The Affiliated Hospital of Qingdao University

wyjtgzy@163.com+86 156 1588 6677

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026